Published in J Clin Microbiol on February 01, 1994
Serratia infections: from military experiments to current practice. Clin Microbiol Rev (2011) 2.90
Report of six cases of human infection by Serratia plymuthica. J Clin Microbiol (1995) 0.77
Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol (1985) 17.42
The genus Serratia. Annu Rev Microbiol (1978) 3.85
Nomenclature for aerobic and facultative bacteria. Clin Infect Dis (1993) 2.49
Serratia plymuthica sepsis associated with infection of central venous catheter. J Clin Microbiol (1987) 1.57
Isolation of Serratia plymuthica from a human burn site. J Clin Microbiol (1985) 1.39
Serratia plymuthica osteomyelitis following a motorcycle accident. J Clin Microbiol (1988) 1.08
Community-acquired bacteremia caused by Serratia plymuthica. Case report and review of the literature. Diagn Microbiol Infect Dis (1992) 0.86
Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol (2000) 3.39
Antibiotic resistance problems with Helicobacter pylori. Int J Antimicrob Agents (1999) 1.85
Celiac disease in a Chilean population carrying Amerindian traits. J Pediatr Gastroenterol Nutr (2000) 1.53
[Geriatric management of the frail elderly with hip fracture may improve their clinical outcome]. Med Clin (Barc) (2001) 1.41
Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors. J Natl Cancer Inst (1995) 1.40
Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial. J Natl Cancer Inst (2001) 1.15
Incidence trends in pertussis in the Autonomous Region of Madrid, Spain: 1982-2005. Euro Surveill (2007) 1.11
Comparison of three methods for identification of Streptococcus milleri group isolates to species level. Eur J Clin Microbiol Infect Dis (2000) 1.11
Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (2002) 1.10
PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. J Clin Microbiol (2000) 1.09
A 9 year study of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children. J Antimicrob Chemother (2001) 1.07
Five-year analysis of antimicrobial susceptibility of the Streptococcus milleri group. Eur J Clin Microbiol Infect Dis (1999) 1.07
[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid]. Rev Esp Quimioter (2001) 1.06
Analysis of optical flow constraints. IEEE Trans Image Process (1995) 1.05
cagA gene and vacA alleles in Spanish Helicobacter pylori clinical isolates from patients of different ages. FEMS Immunol Med Microbiol (1999) 1.04
High-level quinolone resistance amongst clinical isolates of Escherichia coli and Klebsiella pneumoniae from Spain. J Antimicrob Chemother (1993) 1.03
A case of endocarditis due to Granulicatella adiacens. Clin Microbiol Infect (2003) 1.01
Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine. Lung Cancer (2011) 1.01
Neoplasms of unknown primary site: a clinicopathological study of autopsied patients. Tumori (1993) 1.01
Clarithromycin resistance stability in Helicobacter pylori: influence of the MIC and type of mutation in the 23S rRNA. J Antimicrob Chemother (2000) 1.00
Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group. J Clin Oncol (2000) 0.99
High frequency of mutations at position 2144 of the 23S rRNA gene in clarithromycin-resistant Helicobacter pylori strains isolated in Spain. J Antimicrob Chemother (1998) 0.99
A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin's lymphoma: investigation of the current protocol through theoretical modelling results. Bull Math Biol (2005) 0.98
Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain. Eur J Clin Microbiol Infect Dis (1998) 0.96
Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol (2002) 0.95
Is there a change in cytomegalovirus seroepidemiology in Spain? Eur J Epidemiol (2004) 0.94
Eradication and follow-up of Helicobacter pylori infection in hemodialysis patients. Nephron (1998) 0.92
Ketanserin and anxiety levels: influence of gender, estrous cycle, ovariectomy and ovarian hormones in female rats. Pharmacol Biochem Behav (1997) 0.91
Scedosporium apiospermum pneumonia after autologous bone marrow transplantation. Eur J Clin Microbiol Infect Dis (1996) 0.90
New features of rubella in Spain: the evidence of an outbreak. Euro Surveill (2004) 0.89
[Cerebral cysticercosis. Clinical manifestations in a high prevalence milieu (author's transl)]. Rev Invest Clin (1976) 0.89
[High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children]. Rev Esp Quimioter (2009) 0.88
Discrepancies between E-test and agar dilution methods for testing metronidazole susceptibility of Helicobacter pylori. J Clin Microbiol (1998) 0.87
cagA and vacA status of Spanish Helicobacter pylori clinical isolates. J Clin Microbiol (1999) 0.86
[Nanobacteria as a cause of renal diseases and vascular calcifying pathology in renal patients ("endovascular lithiasis"]. Enferm Infecc Microbiol Clin (2000) 0.86
Isolation of fluoroquinolone-resistant Escherichia coli and Klebsiella pneumoniae from an infected Hickman catheter. Eur J Clin Microbiol Infect Dis (1990) 0.86
[Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates]. Rev Esp Quimioter (2000) 0.85
Rapid detection of clarithromycin resistant Helicobacter pylori strains in Spanish patients by polymerase chain reaction-restriction fragment length polymorphism. Rev Esp Quimioter (2011) 0.85
Biochemical characterization of chromosomal cephalosporinases from isolates belonging to the Acinetobacter baumannii complex. Clin Microbiol Infect (2001) 0.85
[Prevalence of multiple sclerosis in Ecuador]. Neurologia (2010) 0.85
Fosfomycin and plasmidic resistance. Chemotherapy (1977) 0.84
In vitro activity of CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide, against multiresistant Acinetobacter baumannii strains. Rev Esp Quimioter (2001) 0.84
Ovarian and extragonadal malignant germ-cell tumors in females: a single-institution experience with 43 patients. Ann Oncol (1994) 0.84
Mediastinal non-seminomatous germ cell tumours (MNSGCT) treated with cisplatin-based combination chemotherapy. Ann Oncol (1997) 0.83
High-level mupirocin resistance among Spanish methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1998) 0.83
Investigation of an outbreak of Salmonella typhi in a public school in Madrid. Eur J Epidemiol (1993) 0.83
Optical flow computation using extended constraints. IEEE Trans Image Process (1996) 0.83
SEOM guidelines for the management of non-small-cell lung cancer (NSCLC). Clin Transl Oncol (2009) 0.83
Superinfections by Escherichia coli resistant to fluoroquinolones in immunocompromised patients. J Antimicrob Chemother (1992) 0.82
[Leptotrichia goodfellowii wound infection after a dog bite]. Rev Esp Quimioter (2012) 0.80
Metronidazole resistance and virulence factors in Helicobacter pylori as markers for treatment failure in a paediatric population. FEMS Immunol Med Microbiol (1999) 0.80
Phylogenetic analysis of rubella virus strains from an outbreak in Madrid, Spain, from 2004 to 2005. J Clin Microbiol (2008) 0.80
Genetic differences in HLA-DQA1* and DQB1* allelic distributions between celiac and control children in Santiago, Chile. Hum Immunol (1999) 0.80
Late detection of a shigellosis outbreak in a school in Madrid. Euro Surveill (2005) 0.80
In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1996) 0.80
Detection of decreased susceptibility to fluoroquinolones in Salmonella spp. by five different methods including real-time polymerase chain reaction (PCR). Int J Antimicrob Agents (2007) 0.79
Successful pregnancies in patients with prosthetic mitral valves. Mich Med (1966) 0.79
Acridine orange stain in the early detection of bacteria in blood cultures. Eur J Clin Microbiol (1984) 0.78
[Relationship between antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates]. Rev Esp Quimioter (1999) 0.78
[Outbreak of measles in the population of Spanish origin in North Madrid]. An Pediatr (Barc) (2012) 0.78
Prevalence of CagA and VacA antibodies in children with Helicobacter pylori-associated peptic ulcer compared to prevalence in pediatric patients with active or nonactive chronic gastritis. Clin Diagn Lab Immunol (2000) 0.78
[Plants with antimicrobial action]. Rev Esp Quimioter (2003) 0.78
[The Helicobacter pylori adhesion gene: relation with the origin of the isolates and associated disease]. Enferm Infecc Microbiol Clin (1999) 0.77
Community-acquired urinary tract infection caused by vancomycin-resistant Enterococcus faecalis clinical isolate. Rev Esp Quimioter (2004) 0.77
[Wilson's disease: a review apropos of a clinical experience in 16 patients]. Rev Med Chil (1995) 0.77
Circulation of mumps virus genotypes in Spain from 1996 to 2007. J Clin Microbiol (2010) 0.77
[Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors]. Rev Esp Quimioter (2006) 0.77
[Susceptibility pattern of Acinetobacter baumannii clinical isolates in Madrid vs. Hong Kong]. Rev Esp Quimioter (2006) 0.76
Seropositivity to a major allergen of Anisakis simplex, Ani s 1, in dyspeptic patients with Helicobacter pylori infection: histological and laboratory findings and clinical significance. Clin Microbiol Infect (2006) 0.76
[Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens]. Rev Esp Quimioter (1998) 0.76
[Factors associated with functional deterioration during hospitalization in the elderly admitted for acute diseases]. Rev Clin Esp (2000) 0.75
Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain. Clin Transl Oncol (2011) 0.75
[In vitro activity of furazolidone and nitrofurantoin in Helicobacter pylori clinical isolates and study of mutation rate]. Rev Esp Quimioter (2005) 0.75
[Seasonal incidence of diarrhea caused by Shigella]. Rev Sanid Hig Publica (Madr) (1985) 0.75
[Evaluation of the cut-off point in the serological diagnosis of Helicobacter pylori infection in children using an enzyme immunoassay technique]. Enferm Infecc Microbiol Clin (1993) 0.75
[Epidemiology of diarrhea caused by Campylobacter]. Rev Sanid Hig Publica (Madr) (1985) 0.75
[Species of Shigella isolated in a 4-year period and antimicrobial sensitivity]. Rev Sanid Hig Publica (Madr) (1985) 0.75
[Yersinia enterocolitica in fecal cultures: 5 years' experience]. Rev Sanid Hig Publica (Madr) (1985) 0.75